Properties (79)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
gptkb:Gene_Therapies,_Inc.
gptkb:Fumapharm_AG gptkb:Zymeworks gptkb:Acorda_Therapeutics gptkb:Idec_Pharmaceuticals gptkb:Zymeworks_Inc. gptkb:Nightstar_Therapeutics |
| gptkbp:CEO |
gptkb:Michel_Vounatsos
|
| gptkbp:clinicalTrials |
gptkb:Guillain-Barré_syndrome
gptkb:myasthenia_gravis gptkb:schizophrenia gptkb:Huntington's_disease Alzheimer's disease Parkinson's disease depression amyotrophic lateral sclerosis chronic pain sleep disorders anxiety disorders bipolar disorder traumatic brain injury attention deficit hyperactivity disorder multiple sclerosis peripheral neuropathy post-traumatic stress disorder substance use disorders eating disorders neurodegenerative disorders obsessive-compulsive disorder cognitive impairment frontotemporal dementia neurodevelopmental disorders autism spectrum disorder spinal cord injury cerebral palsy spinal muscular atrophy chronic inflammatory demyelinating polyneuropathy relapsing forms of multiple sclerosis neuropathic pain acute ischemic stroke dementia with Lewy bodies neuromyelitis optica post-stroke recovery primary progressive multiple sclerosis progressive multifocal leukoencephalopathy vascular_dementia |
| gptkbp:employees |
7000
7,000 (2020) |
| gptkbp:focus |
neurodegenerative diseases
multiple sclerosis neurological disorders |
| gptkbp:founded |
1978
|
| gptkbp:founder |
gptkb:M._A._(Marty)_Houghton
|
| gptkbp:headCoach |
7,500 (2021)
7000 (2021) |
| gptkbp:headquarters |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Biogen Idec
|
| gptkbp:industry |
Biotechnology
|
| gptkbp:market |
$40 billion (2021)
|
| gptkbp:partnerships |
gptkb:Samsung_Bioepis
gptkb:Ionis_Pharmaceuticals |
| gptkbp:products |
gptkb:Tecfidera
gptkb:Spinraza gptkb:Avonex gptkb:Tysabri |
| gptkbp:researchAndDevelopment |
$3.5 billion (2020)
|
| gptkbp:researchFocus |
neurodegenerative diseases
neurological diseases |
| gptkbp:revenue |
$13.45 billion (2020)
$11.4 billion (2020) |
| gptkbp:stockSymbol |
gptkb:BIIB
|
| gptkbp:subsidiary |
gptkb:Biogen_Idec_Ltd.
gptkb:Biogen_Idec_MA_Inc. gptkb:Biogen_Idec_Europe_GmbH gptkb:Biogen_Idec_Canada_Inc. Biogen_International_GmbH |
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
www.biogen.com
|